Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.38%
#4 aPriori aPriori +129.43%
#5 Bedrock Bedrock +68.55%
#6 Cysic Cysic +48.18%
#7 Prom Prom +41.94%
#8 Playnance Playnance +35.15%
#9 Nillion Nillion +25.56%
#10 Bitway Bitway +25.33%
Coin of the day
Wrapped One Wrapped One
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Classifica tra le azioni #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Prezzo delle azioni
$0.00023723
Ultima sincronizzazione: 2024-08-26
Capitalizzazione di mercato
$1.41K
Variazione (1 giorno)
111.67%
Variazione (1 anno)
0.00%
Paese
FR
Scambia Pharnext S.A. (ALPHA)

Categoria

Healthcare
Rapporto P/B per Pharnext S.A. (ALPHA)
Rapporto P/B al August 2026 TTM: 0.00
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Pharnext S.A., il rapporto P/B attuale (TTM) è 0.00. Alla fine del 2022, era pari a -303.89M.
Storico del rapporto P/B per Pharnext S.A. da 2012 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 0.00 -100.00%
2023 -0.02 -100.00%
2022 -303.89M -100.00%
2021 -18.548T -96.18%
2020 -485.040T -66.25%
2019 -1.44Qa 95.99%
2018 -733.358T -44.70%
2017 -1.33Qa -129.61%
2016 4.48Qa -660.02%
2015 -799.743T -45.58%
2014 -1.47Qa -64.17%
2013 -4.10Qa 0.00%
2012 0.00 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR